Painful diabetic polyneuropathy is a common manifestation of diabetes mellitus 1 . Painful diabetic polyneuropathy significantly affect on the quality of life, sleep, mood, mobility, ability to motor activities and social behaviors of patients 2 . High prevalence of diabetes and consequently painful neuropathy limits the daily activities of the patients 3 .
Introduction
Painful diabetic polyneuropathy is a common manifestation of diabetes mellitus 1 . Painful diabetic polyneuropathy significantly affect on the quality of life, sleep, mood, mobility, ability to motor activities and social behaviors of patients 2 . High prevalence of diabetes and consequently painful neuropathy limits the daily activities of the patients 3 .
Diabetic neuropathy is one of the most underestimated, very common and early among the complications of diabetes mellitus (DM) 4 . The most common type of neuropathy in DM is diabetic peripheral neuropathy (DPN), with up to 50% of patients experiencing some degree of painful symptoms and 10% to 20% having symptoms severe enough to warrant treatment 5 . A classic population-based study found some degree of neuropathy in 66.0% of patients with DM. Among those 54.0% with type 1 and 45.0% with type 2 DM had DPN. This study has also shown that 15% of DPN in type 1 and 13% in type 2 DM are symptomatic 6 . Prevalence of neuropathic symptoms increases with the duration of diabetes and quality of glycemic control 7 . Although 7.5% diabetics, at the time of diagnosis, can have neuropathy, the incidence increases to about 50% after 20 to 25 years of diabetic life 3 . Up to 25% of individuals with diabetes develop painful diabetic neuropathy, more than 14 million people in the United States with diabetes mellitus, nearly a quarter, suffer from painful diabetic neuropathy 5 . In this context this present study was undertaken to see the demographic characteristics of diabetic neuropathy patients.
Materials and Methods
This was a descriptive type of cross-sectional study conducted from January 2012 to December 2013 for a period of two (2) years.This study was carried out in the Department of Neurology including Neuropathy Clinic andin collaboration with Department of Endocrinology at Banghabandhu Sheikh Mujib Medical University, Dhaka. Adult diabetic patients presented with neuropathic pain with symmetrical involvement of distal limbs from indoor and outpatient department of Neurology including Neuropathy clinic as well as indoor and outpatient department of Endocrinology, BSMMU were enrolled in the study population. Patients with the age group of below 18 and above 65 years, having the history of drug hypersensitivity reaction, impaired hepatic and renal function, pregnant women and in lactation were excluded from this study. All respondents were selected purposively and convenientlyfrom theaforementioned study places. Data collection sheet was used to collect patient's information. Data was collected by face to face interview. Information was collected by taking medical history and clinical examinations and subsequent laboratory investigations. Data was analyzed by computer with the help of SPSS version 21.0 software package. All data was recorded systematically in a preformed data collection sheet and expressed the quantitative variables as mean±SD. It was analyzed for categorical variables by using chi-squared test and for continuous variable t-test used. For all statistical tests, we considered p value <0.05 as statistically significant. Prior to the commencement of this study, the research protocol was approved by the Institutional Review Board (IRB) of BSMMU, Dhaka. Results A total number of 102 cases were recruited for this study who were clinically diagnosed as painful diabetic polyneuropathy. In this study female was predominant than male which was 55(53.9%) cases and 47(46.1%) cases respectively. The male and female ratio was 1:1.2 (Table I) .
Table-I: Distribution of the Respondents by Gender (n=102).
Among 102 patients majority were in the age group of more than 55 years which was 55(53.9%) cases followed by 45 to 54 years, 35 to 44 years and 35 to 44 years which were 30(29.4%) cases, 12(11.8%) cases and 5(4.9%) cases respectively. The mean age with SD of the study population was 52.79±9.42 years with the age range of minimum 25 years and the maximum was 65 years (Table II) . Table- Among 102 patients type II DM was predominate than type I patients which were 95(92.2%) cases and 8(7.8%) cases respectively. The ratio of type I and type II DM was 1:11.7 (Table III) .
Table-III: Distribution of the Respondents by Type of DM (n=102).
The mean duration of DM with SD was 6.51±3.6 years. However the mean duration of neuropathic pain was 1.68±1.155 years (Table IV) . Among 102 patients majority were in the age group of more than 55 years which was 55(53.9%) cases followed by 45 to 54 years, 35 to 44 years and 35 to 44 years which were 30(29.4%) cases, 12(11.8%) cases and 5(4.9%) cases respectively. The mean age with SD of the study population was 52.79±9.42 years with the age range of minimum 25 years and the maximum was 65 years. Interestingly, age has no influence on sensory symptoms in both neuropathic entities. The fact that younger diabetic patients have slightly more intense neuropathic pain was unexpected. Again, the explanation might be the selection bias in specialized pain centers. Many younger patients with mild pain have been missed.
Painful diabetes neuropathy is common in type II diabetes mellitus. In this study among 102 patients type II DM was predominate than type I patients which were 95(92.2%) cases and 8(7.8%) cases respectively. The ratio of type I and type II DM was 1:11.7. In a study conducted by Zeigler et al 8 pain in the feet and legs occurred in 11.6% of insulin dependent diabetics and 32.1% of noninsulin dependent diabetics.
The typical DPN is a chronic, symmetrical, length-dependent sensorimotor polyneuropathy (DSPN) and is thought to be the most common variety 9 . It develops on or with a background of long standing hyperglycemia, associated metabolic derangements increased polyol flux, accumulation of advanced glycation end products, oxidative stress, and lipid alterations among other metabolic abnormalities and cardiovascular risk factors [10] [11] . Alterations of microvessels, similar to those observed in diabetic retinopathy and nephropathy, appear to be associated with the pathologic alterations of nerves 12 . Total hyperglycemic exposure is perhaps the most important risk covariate 13 . This variety has been shown to be stabilized, perhaps even improved, by rigorous glycemic control. This polyneuropathy has been shown to be statistically associated with retinopathy and nephropathy 14 . Autonomic dysfunction and neuropathic pain may develop over time. The atypical DPNs are different from DSPN in several important features, i.e., onset, course, manifestations, associations, and perhaps putative mechanisms 15 . They appear to be intercurrent varieties, developing at any time during the course of a patient's diabetes 16 . Onset of symptoms may be acute, subacute, or chronic, but the course is usually monophasic or fluctuating over time. Pain and autonomic symptoms are typical features 17 and altered immunity has been suggested. Studies have suggested that impaired fasting glucose or impaired glucose tolerance (IGT) is more common in chronic idiopathic axonal polyneuropathy 18 .
Conclusion
Diabetic neuropathy is a permanent irreversible debilitating but preventable microvascular complication.
It produce a significant devastating effect on quality of life. Prevalence higher with increasing age and duration of diabetic life. Strict glycemic control improve quality of life.
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